Abeona Therapeutics Statistics Share Statistics Abeona Therapeutics has 51.28M
shares outstanding. The number of shares has increased by 18.11%
in one year.
Shares Outstanding 51.28M Shares Change (YoY) 18.11% Shares Change (QoQ) 5.4% Owned by Institutions (%) 0% Shares Floating 45.61M Failed to Deliver (FTD) Shares 10 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 9.03M, so 17.61% of the outstanding
shares have been sold short.
Short Interest 9.03M Short % of Shares Out 17.61% Short % of Float 18.85% Short Ratio (days to cover) 13.22
Valuation Ratios The PE ratio is -3.59 and the forward
PE ratio is 183.67.
Abeona Therapeutics's PEG ratio is
0.09.
PE Ratio -3.59 Forward PE 183.67 PS Ratio 0 Forward PS 2.4 PB Ratio 5.19 P/FCF Ratio -3.91 PEG Ratio 0.09
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Abeona Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.08,
with a Debt / Equity ratio of 0.52.
Current Ratio 6.08 Quick Ratio 6.08 Debt / Equity 0.52 Debt / EBITDA -0.41 Debt / FCF -0.39 Interest Coverage -15.26
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-468.63K Employee Count 136 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -6.41% in the
last 52 weeks. The beta is 1.67, so Abeona Therapeutics's
price volatility has been higher than the market average.
Beta 1.67 52-Week Price Change -6.41% 50-Day Moving Average 6.53 200-Day Moving Average 5.84 Relative Strength Index (RSI) 32.55 Average Volume (20 Days) 888,660
Income Statement
Revenue n/a Gross Profit -2.91M Operating Income -64.21M Net Income -63.73M EBITDA -56.62M EBIT -59.53M Earnings Per Share (EPS) -1.55
Full Income Statement Balance Sheet The company has 23.36M in cash and 23.05M in
debt, giving a net cash position of 309K.
Cash & Cash Equivalents 23.36M Total Debt 23.05M Net Cash 309K Retained Earnings -813.26M Total Assets 246.23M Working Capital 197.75M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -56.02M
and capital expenditures -2.45M, giving a free cash flow of -58.46M.
Operating Cash Flow -56.02M Capital Expenditures -2.45M Free Cash Flow -58.46M FCF Per Share -1.42
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ABEO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ABEO is $20,
which is 260.4% higher than the current price. The consensus rating is "Buy".
Price Target $20 Price Target Difference 260.4% Analyst Consensus Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 5, 2022. It was a
backward
split with a ratio of 1:25.
Last Split Date Jul 5, 2022 Split Type backward Split Ratio 1:25
Scores Altman Z-Score 0.37 Piotroski F-Score 5
